Mercator Medical stock gains 4.06 percent as H1 profit rises 170 percent

Published on 10/06/2026 at 12:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mercator Medical stock posted PLN 337.2 million in first-half revenue on October 1, 2026, up 16 percent year over year. Net profit reached PLN 57.7 million as cost pressure persists.

Mercator Medical, PLMRCTR00015, Illustration mit AI erstellt.

Mercator Medical (ISIN PLMRCTR00015) stock gained 4.06 percent to PLN 59 on the Warsaw Stock Exchange on October 6, 2026, as investors weighed a sharp improvement in first-half profitability. In its October 1, 2026 release, Mercator Medical reported revenue growth, stronger EBITDA and a 170 percent increase in net profit.

Profit growth reshapes the first half

Consolidated sales revenue reached PLN 337.2 million in the first half of 2026, up 16 percent from the same period a year earlier. EBITDA rose to PLN 61.4 million from negative PLN 0.7 million, while net profit increased 170 percent to PLN 57.7 million, according to Mercator Medical.

The sales mix helped explain the operating improvement. United States revenue reached PLN 136.8 million, up 29.3 percent year over year, and represented 40.6 percent of group sales in the first half.

Higher costs remain the counterweight

The company said demand should stabilize in the coming quarters, while production and purchasing costs remain elevated and may affect margins. That warning matters because the first-half earnings improvement was driven by wider margins, a more favorable sales mix and better purchasing terms, as Mercator Medical stated on October 1, 2026.

Geographic performance was uneven. Sales in Poland rose 17.1 percent to PLN 81 million, Czech revenue increased 56.8 percent to PLN 13.5 million, and German revenue advanced 32.2 percent to PLN 12.4 million, while Romania declined 11 percent.

Stock remains below its yearly high

Mercator Medical stock was trading at PLN 59 on the Warsaw Stock Exchange on October 6, 2026, at 12:32 p.m. CEST, up 4.06 percent from the PLN 56.70 previous close. Its market capitalization was PLN 539.5 million, and the share price stood 7.38 percent below the 52-week high of PLN 63.70.